Morgenstern J, Langenbucher J, Labouvie E W
Center of Alcohol Studies, Rutgers, State University of New Jersey 08855-0969.
Addiction. 1994 Sep;89(9):1105-13. doi: 10.1111/j.1360-0443.1994.tb02787.x.
DSM-III-R and proposed DSM-IV schemes for the diagnosis of psychoactive substance use disorders are based largely on the dependence syndrome concept. However, there is an absence of empirical support for the generalizability of the dependence syndrome across substances. This study examines how consistently proposed DSM-IV dependence criteria function to measure dependence across seven substances: alcohol, cannabis, cocaine, stimulants, hallucinogens, sedatives and opiates. Using structured research diagnostic interviews, dependence diagnoses were determined for 295 American subjects in treatment for alcohol/drug problems. Several factor analytic techniques were used to assess whether criteria formed single dimensions and how consistently individual criteria measured dependence across substances. The ability and consistency of criteria to measure a continuum of severity across substances were also assessed. Only subjects who used the substance at least six times were entered in the analyses. Overall, results provide strong support for the DSM approach for alcohol, cannabis, cocaine, stimulants, sedatives and opiates, but not for hallucinogens. Results indicate that a single strong factor adequately described the criteria for these six substances. All criteria loaded strongly and uniformly on single factors indicating that all were good measures of dependence. Criteria provided a dimensional measure of severity based on several indices for these substances. In addition, four criteria provided relatively stable indicators of high or low severity across these substances. Results did not support the use of dependence criteria for hallucinogens as these criteria did not form a single factor. Results suggest that very few hallucinogen users experience an inability to cut down or control use, a key indicator of loss of control.
《精神疾病诊断与统计手册》第三版修订本(DSM-III-R)以及提议的《精神疾病诊断与统计手册》第四版(DSM-IV)中关于精神活性物质使用障碍的诊断方案,很大程度上是基于依赖综合征的概念。然而,对于依赖综合征在不同物质间的普遍性,缺乏实证支持。本研究考察了提议的DSM-IV依赖标准在衡量七种物质(酒精、大麻、可卡因、兴奋剂、致幻剂、镇静剂和阿片类药物)的依赖情况时的一致性。通过结构化的研究诊断访谈,确定了295名接受酒精/药物问题治疗的美国受试者的依赖诊断。使用了几种因子分析技术来评估这些标准是否形成单一维度,以及各个标准在不同物质间衡量依赖的一致性。还评估了这些标准在不同物质间衡量严重程度连续体的能力和一致性。仅将至少使用过该物质六次的受试者纳入分析。总体而言,结果为DSM对酒精、大麻、可卡因、兴奋剂、镇静剂和阿片类药物的诊断方法提供了有力支持,但对致幻剂则不然。结果表明,一个单一的强因子充分描述了这六种物质的标准。所有标准都在单一因子上有很强且一致的载荷,表明所有标准都是依赖的良好衡量指标。这些标准基于几种指标为这些物质提供了严重程度的维度衡量。此外,四个标准为这些物质间的高或低严重程度提供了相对稳定的指标。结果不支持将依赖标准用于致幻剂,因为这些标准未形成单一因子。结果表明,很少有致幻剂使用者经历无法减少或控制使用的情况,而这是失控的关键指标。